Company Ambrinomed Srl with Fiscal Code 36269817
recorded a turnover of 2024 of
110.173,
with a net profit of
58.661
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ambrinomed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
10.566
44.665
64.499
60.729
59.626
91.869
105.575
113.635
110.173
Total Income - EUR
-
10.566
45.025
64.499
60.729
60.624
91.921
105.653
113.635
110.437
Total Expenses - EUR
-
5.224
20.011
19.857
19.846
26.684
62.445
49.195
49.731
48.529
Gross Profit/Loss - EUR
-
5.342
25.014
44.642
40.883
33.940
29.476
56.459
63.905
61.907
Net Profit/Loss - EUR
-
5.236
24.567
43.997
40.276
33.549
28.727
55.423
62.791
58.661
Employees
-
2
2
2
2
2
2
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -2.5%, from 113.635 euro in the year 2023, to 110.173 euro in 2024.
The Net Profit decreased by -3.780 euro, from 62.791 euro in 2023, to 58.661 in the last year.
Check the financial reports for the company - Ambrinomed Srl
Financial Rating - AMBRINOMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ambrinomed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ambrinomed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ambrinomed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
20.174 euro in 2024 which includes Inventories of
0 euro, Receivables of
44 euro and cash availability of
20.130 euro.
The company's Equity was valued at
58.709 euro, while total Liabilities amounted to
5.231 euro.
Equity decreased by -4.300 euro, from 63.363 euro in 2023, to 58.709 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ambrinomed Srl